Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SMC rejects Perjeta (pertuzumab) for NHS use for breast cancer

europeanpharmaceuticalreviewJune 16, 2017

Tag: SMC , Breast Cancer

PharmaSources Customer Service